治疗急性心力衰竭的新鲜事物和实际的前景
Benjamin Deniau1, Ayu Asakage2, Koji Takagi3
1Department of Anesthesia, Burn and Critical Care, University Hospitals Saint-Louis - Lariboisière, AP-HP, Paris, France; UMR-S 942, INSERM, MASCOT, Paris University, Paris, France; Paris Cité University, Paris, France; FHU PROMICE, Paris, France; INI CRCT Network, Nancy, France.
Anaesthesia, critical care & pain medicine
|January 23, 2025
概括
急性心力衰竭 (AHF) 管理侧重于缓解血压,快速的目标导向疗法和早期随访. 心脏性休克是一种严重的AHF并发症,需要及时干预以防止器官衰竭.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
背景情况:
- 急性心力衰竭 (AHF) 是老年人死亡和住院的主要原因.
- 心脏性休克是一种严重的AHF表现,由心脏输出量低和拥堵引起,通常是心肌梗塞后.
研究的目的:
- 总结目前对AHF和心脏性休克的治疗策略.
- 根据最近的指导方针和试验,为麻醉师和重症治疗师提供必要的知识.
主要方法:
- 审查最近的随机临床试验和指导方针.
- 对AHF和心脏性休克的流行病学和病理生理学数据的综合.
主要成果:
- 强调使用循环利尿剂作为关键治疗组件来缓解血压.
- 强调快速目标导向医疗疗法和出院后早期随访的重要性.
结论:
- 对AHF和心脏性休克的有效管理依赖于及时干预和基于证据的治疗方法.
- 麻醉科医生和重症监护医生必须了解最新的进展,以获得最佳的患者结果.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
376
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
376
Heart Failure Drugs: Inotropic Agents
510
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
510
Heart Failure Drugs: β-Blockers
314
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
314
Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
Antianginal Drugs: Nitrates and β-Blockers
511
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
511
Adrenergic Agonists: Therapeutic Uses
723
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
723


